Helios Technologies (HLIO) Q2 2026 earnings review
Massive Operating Leverage Drives Beat and Raise
Helios Technologies delivered a blowout Q2 2026, combining 16% pro-forma sales growth with aggressive margin expansion. Stripping out the noise of last year's Custom Fluidpower (CFP) divestiture, the underlying business is firing on all cylinders. Adjusted EPS surged 49% to $0.88, crushing expectations, while the company rapidly deleveraged its balance sheet to a pristine 1.4x Net Debt-to-EBITDA. Management raised full-year guidance across the board, citing strong volume outperformance and operational leverage, though a softer Q3 sequential revenue guide hints at second-half conservatism.
🐂 Bull Case
The Electronics segment shifted from a margin laggard to a profit engine. Segment gross margin expanded 530 bps YoY to 34.6%, aligning perfectly with Hydraulics and proving the high-margin product mix strategy is working.
Helios generated a Q2 record $42 million in operating cash flow. Net debt-to-adjusted EBITDA dropped from 2.6x a year ago to just 1.4x, providing immense capital allocation optionality for M&A or expanded buybacks.
🐻 Bear Case
Despite raising the full-year outlook, Q3 guidance of $215-$222 million implies a sequential deceleration from Q2's $231.9 million. The headline 'growth momentum' narrative masks a cautious step-down in the back half of the year.
While the Americas and EMEA grew nicely, APAC Hydraulics sales fell 8% YoY to $37.4M, highlighting persistent macro and end-market weakness in the Asian industrial and agricultural sectors.
⚖️ Verdict: 🟢
Bullish. Helios is successfully absorbing volume growth and translating it directly into outsized margin expansion. While H2 guidance is mildly conservative sequentially, the 16% pro-forma growth and stellar free cash flow generation make this a highly compelling fundamental story.
Key Themes
Electronics Segment Reversal to Growth and Profitability
The Electronics segment was the absolute star of Q2. Sales accelerated 19% YoY to $85.5 million, but the real story is profitability. Operating income skyrocketed 90% YoY to $11.2 million. Operating margin expanded 490 bps to 13.1%, and gross margin matched the legacy Hydraulics business at 34.6%. This proves that recent execution issues are fully resolved and new high-margin product streams are scaling.
Innovation-Led Mix Shift
Helios continues to reap the benefits of its accelerated R&D cycle. The ramp-up of specific technology innovations, such as the QM-EH cartridge valve, Faster's thermal management products for AI data centers, and the OpenView S70 display, are creating incremental, non-cannibalizing revenue streams that carry accretive gross margins.
Rapid Deleveraging and Cash Generation
Accelerating cash generation is structurally de-risking the company. Record Q2 operating cash flow of $42 million drove trailing leverage down to 1.4x (from 2.6x a year ago). The company achieved its sub-2.0x target early, drastically reducing interest expense vulnerability and unlocking dry powder for strategic deployments.
Sequential Deceleration Contradicts the 'Momentum' Narrative
Management's press release touts 'Profitable Sales Growth Momentum Continues,' but the specific guidance data points to a slowdown. Q3 sales guidance of $215-$222 million represents a distinct sequential drop from Q2's $231.9 million. While year-over-year comparisons are muddied by the CFP divestiture, the raw dollar volume step-down suggests H2 demand will not match the H1 run rate.
APAC Hydraulics Remains a Sore Spot
While overall Hydraulics sales grew 4%, the APAC region acted as a significant anchor, contracting 8% YoY to $37.4 million. This points to ongoing malaise in Chinese/Asian industrial and agricultural end-markets, requiring Europe and the Americas to carry the full weight of the segment's growth.
Macro Volatility and Tariff Noise
Helios recognized a $1 million net benefit from IEEPA tariff refunds in Q2, which artificially padded gross profit. While a win, it highlights the company's ongoing sensitivity to a fluid global trade environment. Management explicitly cited geopolitical uncertainty and tariffs as reasons for H2 caution in their previous quarter; investors must monitor if these tailwinds revert to headwinds.
Other KPIs
Accelerating significantly. Grew 25% YoY, vastly outpacing the 9% reported revenue growth. Adjusted EBITDA margin expanded 260 basis points to 21.2%, exceeding the company's long-term 20% baseline target and showcasing the immense operational leverage built into the newly restructured business model.
Strong conversion metric. Generated robust free cash flow on the back of $42 million in operating cash. This funded the 118th consecutive dividend and a $6.0 million stock repurchase, while still allowing the company to aggressively pay down debt.
Guidance
Accelerating. Raised from the prior outlook of $840 - $870 million. The midpoint ($890M) represents roughly 6% reported YoY growth versus FY25's $839M, but implies high single-to-double-digit growth on a pro-forma basis (excluding the CFP divestiture).
Accelerating. A massive raise from the prior $2.75 - $3.00 guide. The new midpoint of $3.15 implies 23% YoY growth compared to FY25 ($2.56), proving that incremental volume is dropping cleanly to the bottom line.
Accelerating. The floor was lifted from 19.5% to 20.2%. This firmly cements Helios's profitability profile back in the >20% tier on a full-year basis, shaking off the margin compression seen in mid-2025.
Decelerating sequentially. While the annual guide is robust, the immediate Q3 outlook is a step down from the $231.9M achieved in Q2. Management is likely baking in seasonality and macro conservatism into the immediate next quarter.
Key Questions
Q3 Sequential Decline Drivers
Your Q3 sales guidance implies an $11-$15 million sequential decline from Q2. How much of this is driven by normal seasonal patterns versus specific pockets of macro or end-market softening you are seeing in the order book?
APAC Hydraulics Turnaround
APAC Hydraulics was the lone regional weak spot, down 8%. What is the specific operational or end-market hurdle in Asia right now, and when do you anticipate a return to growth in that theater?
Capital Allocation with 1.4x Leverage
With Net Debt-to-Adjusted EBITDA down to 1.4x—well below your historical 2.0x target—does this accelerate your timeline for larger strategic M&A, or will excess free cash flow be increasingly funneled into the share repurchase program?